The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity

scientific article published in June 2005

The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TAAP.2004.10.005
P698PubMed publication ID15893540

P2093author name stringPaul S Thomas
Colleen Bruce
P433issue2
P921main subjectasthmaQ35869
P304page(s)126-132
P577publication date2005-06-01
P1433published inToxicology and Applied PharmacologyQ2446974
P1476titleThe effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity
P478volume205

Reverse relations

cites work (P2860)
Q33600138Chronic obstructive pulmonary disease: towards pharmacogenetics
Q37071004Future therapeutic treatment of COPD: struggle between oxidants and cytokines
Q40382144Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population
Q36376519Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
Q35816380Involvement of Toll-like receptor 2 and epidermal growth factor receptor signaling in epithelial expression of airway remodeling factors
Q42092256Long-term use of doxycycline can improve chronic asthma and possibly remodeling: the result of a pilot observation
Q46227261Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency
Q36712749Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted
Q47923013Potential Involvement of the Epidermal Growth Factor Receptor Ligand Epiregulin and Matrix Metalloproteinase-1 in Pathogenesis of Chronic Rhinosinusitis
Q37578310Targeting lung inflammation: novel therapies for the treatment of COPD.
Q36793292Tumor necrosis factor inhibitors for the treatment of asthma

Search more.